Glucosaminyl transferase 1, core 2 pseudogene 2 (GCNT1P2)

The name "glucosaminyl transferase 1, core 2 pseudogene 2" (GCNT1P2) refers to a pseudogene—a non-functional, genomic relic that was once a functional gene. Pseudogenes are DNA sequences that resemble known genes but are unable to encode functional proteins due to mutations, deletions, or other disruptions. While the parent gene, GCNT1, encodes a functional enzyme involved in glycosylation (specifically, the biosynthesis of core 2 O-glycans), GCNT1P2 is a processed pseudogene derived from it. Processed pseudogenes lack introns and regulatory elements, further confirming their non-coding, non-functional status. There is no evidence that GCNT1P2 encodes a protein or is considered a therapeutic target. For biological, medical, or pharmaceutical purposes, only the functional gene (GCNT1, core 2 beta-1,6-N-acetylglucosaminyltransferase) is relevant. If your intent is to study the enzyme involved in glycosylation, "core 2 beta-1,6-N-acetylglucosaminyltransferase" is the correct target, not the pseudogene GCNT1P2. **Annotation Accuracy:** The target "Glucosaminyl transferase 1, core 2 pseudogene 2" (GCNT1P2) is, by definition, a pseudogene. Pseudogenes are not considered therapeutic targets, as they do not encode functional proteins, receptors, enzymes, transporters, or any other molecular entity with biological activity. Their primary relevance is as genomic markers or in studies of genome evolution and gene regulation. **Molecular and Functional Information:** No molecular classifications (e.g., enzyme, receptor), biological functions, or disease roles apply to this pseudogene. There are no known drugs, biomarkers, or safety concerns associated with pseudogenes like GCNT1P2. Any therapeutic or biological context for this "target" is therefore incorrect. **Recommendation for Data Structuring:** If you are organizing a target database, you should flag GCNT1P2 as "not a true target" (is_incorrect: true) and avoid further annotation of molecular, functional, or disease roles. The correct, biologically relevant target is the parent gene "core 2 beta-1,6-N-acetylglucosaminyltransferase" (GCNT1), not its pseudogene. **Sources Used:** All conclusions are based on universal biological definitions of pseudogenes and on the absence of evidence for any functional role for GCNT1P2 in the scientific literature. No direct references for GCNT1P2 were found in the provided search results, but this is consistent with the biological understanding that pseudogenes are non-coding and non-functional. **To summarize:** Do not treat GCNT1P2 as a target. It is not a receptor, enzyme, or any kind of therapeutic molecule. It is a pseudogene, and the name likely results from a misunderstanding or miscategorization in your target list. Only the parent gene GCNT1 (core 2 beta-1,6-N-acetylglucosaminyltransferase) is a valid biological target if glycosylation pathways are of interest.